Nuvectis Pharma
NVCT
NVCT
41 hedge funds and large institutions have $7.63M invested in Nuvectis Pharma in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
10
Reduced
12
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
$756K |
| 2 |
Goldman Sachs
New York
|
$390K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
$147K |
| 4 |
Jane Street
New York
|
$108K |
| 5 |
Citadel Advisors
Miami,
Florida
|
$94.6K |
Top Sellers
| 1 |
BlackRock
New York
|
$528K |
| 2 |
State Street
Boston,
Massachusetts
|
$96.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$337K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.59M |
| 5 |
Morgan Stanley
New York
|
$64.6K |
